Ebarle, Jhayden, -. E.
HRN: 23-28-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/02/2023
07/09/2023
IV
50mg
Q8hours
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes